The Federal Circuit has affirmed a district court’s summary judgment ruling in favor of the US Patent and Trademark Office (USPTO) following a civil action by ImmunoGen seeking to obtain a patent after an unsuccessful ex parte appeal of a patent ap…
Read More
Read More
The Federal Circuit has overturned a decision by the International Trade Commission (ITC or Commission) on a polycrystalline diamond compound owned by US Synthetic. The case is US Synthetic Corp. v. International Trade Commission. US Synthetic Corp.…
Read More
Read More
The Federal Circuit has found that the Patent Trial and Appeal Board (PTAB or Board) construed patent claims erroneously but that the error was harmless. HD Silicon Solutions LLC (“HDSS”) appealed from a decision of the PTAB holding claims 1–7…
Read More
Read More
Senators Chris Coons (D-DE) and Tom Cotton (R-AR) have reintroduced the Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act. The Act, first introduced in July of 2024, would restore the rebu…
Read More
Read More
In a non-precedential decision, the Federal Circuit affirmed a decision of the Patent Trial and Appeal Board (PTAB or Board) that certain claims of Qualcomm’s U.S. Patent No. 8,838,949 (titled “Direct Scatter Loading of Executable Software Im…
Read More
Read More
Artificial Intelligence (AI) in general, and generative AI (GAI) – such as ChatGPT- in particular, continue to be very much in the news. As Reuters reported, on January 21, President Donald Trump announced “a private sector investment of up to $5…
Read More
Read More
The Federal Circuit has affirmed a district court judgment finding that Purdue Pharma’s patent claims to crush-resistant and low-toxicity OxyContin were invalid as obvious. The case involves patents related to Purdue’s formulation of extended-rel…
Read More
Read More
Patents are a form of intellectual property – an asset. However, the value of that asset can be uncertain. As the European Patent Office (EPO) explains, Methods of evaluating patents for business purposes can be divided into quantitative and qualit…
Read More
Read More
The Federal Circuit has vacated and remanded a decision by the Patent Trial and Appeal Board (PTAB or Board), finding that Palo Alto Networks failed to establish that certain claims of Centripetal Networks patents were unpatentable as obvious. The co…
Read More
Read More
The Federal Circuit recently issued two precedential decisions in patent cases. In Galderma Laboratories v. Lupin, the court affirmed a district court’s decision that Lupin’s abbreviated new drug application (ANDA) did not infringe Galderma’s t…
Read More
Read More